S03E17: She takes a pharmaceutical approach to cannabis science

Featured guest: Dot Colagiovanni, senior director of pharmaceutical development for Next Frontier Biosciences. She holds a doctorate in molecular toxicology and environmental health sciences, and specializes in pain, anti-infectives, oncology and inflammatory lung diseases.

LOTS TO TALK ABOUT

•  Whether it’s Big Pharma or lil’ pharma, heavily regulated and scientific approaches to cannabis are the new norm.

•  How cannabinoids interact with different parts of your body, and also how they interact with other intoxicants.

•  Sativa, Indica, Hybrid — does it really make a difference which strain was used to make an edible, if all you’re adding is the compound THC?

TOP MARIJUANA NEWS

Jeff Sessions’ letter to Oregon gov cites “pervasive illicit cannabis cultivation”: Attorney General Jeff Sessions’ marijuana-related missive to Oregon’s top official zeroed in on state police findings that cannabis legalization did little to cull black market activity,…

Continue reading at THeCannabist.com

About The Cannabist

Leave a Reply

Your email address will not be published. Required fields are marked *